We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Level up your trading with our powerful tools and real-time insights all in one place.
The current OBI market cap is 44.44M. The company's latest EPS is CAD -0.0357 and P/E is -3.08.
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Revenue | 464k | 1.79M | 2.57M | 638k | 1.2M |
| Operating Income | -14.03M | -15.87M | -17.52M | -18.76M | -14.81M |
| Net Income | -13.9M | -16.27M | -50.09M | -19.37M | -14.41M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Total Assets | 2.91M | 2.64M | 34.14M | 16.57M | 5.73M |
| Total Liabilities | 28.99M | 36.46M | 4.48M | 4.93M | 3.65M |
| Total Equity | -26.07M | -33.83M | 29.66M | 11.64M | 2.09M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| CAD ($) | CAD ($) | CAD ($) | CAD ($) | CAD ($) | |
| Operating | -7.55M | -6.33M | -12.54M | -16.35M | -13.65M |
| Investing | -33k | 2.9M | -77k | -311k | -177k |
| Financing | 6.58M | 3.83M | 41.9M | -275k | 3.79M |
| Market Cap | 44.44M |
| Price to Earnings Ratio | -3.08 |
| Price to Sales Ratio | 36.67 |
| Price to Cash Ratio | 14.86 |
| Price to Book Ratio | 21.31 |
| Dividend Yield | - |
| Shares Outstanding | 404M |
| Average Volume (1 week) | 700.24k |
| Average Volume (1 Month) | 286.41k |
| 52 Week Change | 17.33% |
| 52 Week High | 11.75 |
| 52 Week Low | 4.50 |
| Spread (Intraday) | 1 (8.7%) |
| Company Name | Ondine Biomedical Inc. |
| Address |
888 - 1100 melville street vancouver, british columbia V6E 4A6 |
| Website | https://ondinebio.com |
| Industry | minrls,earths-ground,treated (3295) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
